Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.
-
Research
- Experts
In The News
View All
Dr. Chris Harle guests on HIMMSCast
Chris Harle, PhD, M.S., was a guest on the HIMSSCast...
Influence
View All
Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers
Published in the journal JAMA Network Open. Here is a...
- Opportunities
- Experts
Influence
February 13, 2020
Regenstrief researchers leading core of national research incubator
Related News
Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers
Published in the journal JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Nicole Fowler,
Brian Dixon named director of biomedical informatics at Regenstrief Institute
A trailblazer in the burgeoning fields of population and public health informatics, Brian Dixon, PhD, MPA, has been named
Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors
Indianapolis – Researchers from Indiana University Indianapolis, Regenstrief Institute and the IU School of Medicine’s Indiana Alzheimer’s Disease Research
Dementia risk prediction: Zero-minute assessment at less than a dollar cost
Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study